COX-2-IN-59
COX-2-IN-59 is a potent and selective COX-2 inhibitor with an IC50 of 0.052 μM. COX-2-IN-59 exhibits 200-fold selectivity over COX-1 (IC50 = 11.16 μM). COX-2-IN-59 reduces COX-2 levels, induces cell cycle arrest, and triggers apoptosis by increasing Bax expression, decreasing Bcl-2 levels, and activating caspase-3. COX-2-IN-59 can be used for the research of colon cancer.
For research use only. We do not sell to patients.
- Formula: C18H19N3O6S
- Molecular Weight:405.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Caspase Isoforms
More
Biological Activity
|
COX-2 0.052 μM (IC50) |
COX-1 11.16 μM (IC50) |
COX-2-IN-59 (compound 5d) (12.5-100 μM; 24 h) inhibits A-549, HOS, MCF‐7, HT‐29, PC3, and Caco‐2 cell growth with IC50s of 4, 67.3, 30.5, 8.5, 29.1, and 2.6 μM, respectively[1].
COX-2-IN-59 (2.6 μM; 24 h) induces G1/S cell cycle arrest, and triggers apoptosis in Caco-2 cells by increasing Bax expression, decreasing Bcl-2 levels, and activating caspase-3[1].
COX-2-IN-59 (2.6 μM; 24 h) significantly reduces COX-2 levels to 3.858 ng/mL (0.494‐fold relative to control) in Caco-2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A-549, HOS, MCF-7, HT-29, PC3, and Caco-2 cells
-
Concentration:12.5-100 μM
-
Incubation Time:24 h
-
Result:Inhibited A-549, HOS, MCF-7, HT-29, PC3, and Caco-2 cell growth with IC50s of 4, 67.3, 30.5, 8.5, 29.1, and 2.6 μM, respectively.
-
Cell Line:Caco-2
-
Concentration:2.6 μM
-
Incubation Time:24 h
-
Result:Demonstrated potent proapoptotic activity in Caco-2 cells, inducing a nearly eightfold increase in total apoptosis (24.38% vs. 3.16% in controls). Induced a dramatic 63-fold increase (15.86% vs. 0.25%) in late apoptosis, and an 11-fold increase (4.85% vs. 0.42%) in early apoptosis.
-
Cell Line:Caco-2
-
Concentration:2.6 μM
-
Incubation Time:24 h
-
Result:Showed a dramatic decrease in G2/M phase cells in the treated group (3.82%) compared to the control group (22.05%). Significantly increased cells in the G0/G1 phase (64.06% vs. 48.29% in control). Induced G1/S phase cell cycle arrest.
-
Cell Line:Caco-2
-
Concentration:2.6 μM
-
Incubation Time:24 h
-
Result:Induced the expression of Bax while suppressing the expression of Bcl‐2, ultimately leading to an increased expression of caspase‐3.
-
Cell Line:Caco-2
-
Concentration:2.6 μM
-
Incubation Time:24 h
-
Result:Significantly reduced COX-2 levels to 3.858 ng/mL (0.494‐fold relative to control).
Chemical Information
-
Molecular Weight 405.42
-
Formula C18H19N3O6S
-
SMILES
CC(NC1=CC=C(OCC(N/N=C/C2=CC=C(OS(=O)(C)=O)C=C2)=O)C=C1)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
COX-2-IN-59 Related Classifications
HY-179125 Related Classifications
Powered by Bioz